APG vs PACB
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APG is a StrongBuy and PACB is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
APG’s FA Score shows that 1 FA rating(s) are green whilePACB’s FA Score has 0 green FA rating(s).
- APG’s FA Score: 1 green, 4 red.
- PACB’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
APG’s TA Score shows that 6 TA indicator(s) are bullish while PACB’s TA Score has 4 bullish TA indicator(s).
- APG’s TA Score: 6 bullish, 3 bearish.
- PACB’s TA Score: 4 bullish, 4 bearish.
Price Growth
APG (@Engineering & Construction) experienced а +5.88% price change this week, while PACB (@Medical Specialties) price change was -0.90% for the same time period.
The average weekly price growth across all stocks in the @Engineering & Construction industry was +5.36%. For the same industry, the average monthly price growth was +12.70%, and the average quarterly price growth was +6.79%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +0.94%. For the same industry, the average monthly price growth was +6.98%, and the average quarterly price growth was -1.17%.
Reported Earning Dates
APG is expected to report earnings on Jul 31, 2025.
PACB is expected to report earnings on Jul 30, 2025.
Industries' Descriptions
@Engineering & Construction (+5.36% weekly)Engineering & Construction includes companies that engage in non-residential construction and contract services, including ventilation, heating and air conditioning (HVAC) services. The level/value of construction & engineering activity is one of the potentially relevant indicators of the health of businesses, and hence of the overall economy. Some of the large-cap U.S. companies in this industry include Jacobs Engineering Group Inc,, AECOM and Quanta Services, Inc.
@Medical Specialties (+0.94% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| APG | PACB | APG / PACB | |
| Capitalization | 12.6B | 977M | 1,290% |
| EBITDA | 776M | -277.28M | -280% |
| Gain YTD | 22.769 | -38.798 | -59% |
| P/E Ratio | 72.39 | N/A | - |
| Revenue | 7.14B | 201M | 3,550% |
| Total Cash | 460M | 631M | 73% |
| Total Debt | 3.04B | 934M | 325% |
APG | PACB | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 48 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | 100 Overvalued | |
PROFIT vs RISK RATING 1..100 | 9 | 100 | |
SMR RATING 1..100 | 82 | 95 | |
PRICE GROWTH RATING 1..100 | 39 | 91 | |
P/E GROWTH RATING 1..100 | 36 | 74 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
APG's Valuation (92) in the null industry is in the same range as PACB (100) in the Biotechnology industry. This means that APG’s stock grew similarly to PACB’s over the last 12 months.
APG's Profit vs Risk Rating (9) in the null industry is significantly better than the same rating for PACB (100) in the Biotechnology industry. This means that APG’s stock grew significantly faster than PACB’s over the last 12 months.
APG's SMR Rating (82) in the null industry is in the same range as PACB (95) in the Biotechnology industry. This means that APG’s stock grew similarly to PACB’s over the last 12 months.
APG's Price Growth Rating (39) in the null industry is somewhat better than the same rating for PACB (91) in the Biotechnology industry. This means that APG’s stock grew somewhat faster than PACB’s over the last 12 months.
APG's P/E Growth Rating (36) in the null industry is somewhat better than the same rating for PACB (74) in the Biotechnology industry. This means that APG’s stock grew somewhat faster than PACB’s over the last 12 months.
| APG | PACB | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 59% | N/A |
| Stochastic ODDS (%) | 4 days ago 61% | 4 days ago 85% |
| Momentum ODDS (%) | 4 days ago 73% | 4 days ago 83% |
| MACD ODDS (%) | 4 days ago 77% | 4 days ago 82% |
| TrendWeek ODDS (%) | 4 days ago 74% | 4 days ago 89% |
| TrendMonth ODDS (%) | 4 days ago 70% | 4 days ago 88% |
| Advances ODDS (%) | 4 days ago 72% | 5 days ago 86% |
| Declines ODDS (%) | N/A | 7 days ago 89% |
| BollingerBands ODDS (%) | 4 days ago 58% | 4 days ago 88% |
| Aroon ODDS (%) | 4 days ago 70% | 4 days ago 88% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GLIN | 43.08 | 1.45 | +3.48% |
| VanEck India Growth Ldrs ETF | |||
| MARB | 20.11 | 0.01 | +0.05% |
| First Trust Merger Arbitrage ETF | |||
| FEX | 102.24 | -0.04 | -0.04% |
| First Trust Large Cap Core AlphaDEX® ETF | |||
| DJAN | 38.26 | -0.03 | -0.08% |
| FT Vest US Equity Dp Bffr ETF Jan | |||
| IWF | 374.75 | -0.71 | -0.19% |
| iShares Russell 1000 Growth ETF | |||
APG and
Correlation & Price change
A.I.dvisor indicates that over the last year, APG has been loosely correlated with EME. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if APG jumps, then EME could also see price increases.
| Ticker / NAME | Correlation To APG | 1D Price Change % | ||
|---|---|---|---|---|
| APG | 100% | +0.55% | ||
| EME - APG | 64% Loosely correlated | -0.18% | ||
| FIX - APG | 64% Loosely correlated | -0.97% | ||
| ACM - APG | 64% Loosely correlated | +0.27% | ||
| MYRG - APG | 63% Loosely correlated | N/A | ||
| ROAD - APG | 62% Loosely correlated | +3.55% | ||
More | ||||
PACB and
Correlation & Price change
A.I.dvisor indicates that over the last year, PACB has been loosely correlated with MASI. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if PACB jumps, then MASI could also see price increases.
| Ticker / NAME | Correlation To PACB | 1D Price Change % | ||
|---|---|---|---|---|
| PACB | 100% | -6.67% | ||
| MASI - PACB | 58% Loosely correlated | +1.95% | ||
| TWST - PACB | 46% Loosely correlated | -5.49% | ||
| LAB - PACB | 46% Loosely correlated | -4.04% | ||
| AZTA - PACB | 45% Loosely correlated | -3.39% | ||
| VCYT - PACB | 45% Loosely correlated | -4.81% | ||
More | ||||